These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2833543)

  • 21. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study.
    Nyström C; Hällström T
    Acta Psychiatr Scand; 1987 Apr; 75(4):377-82. PubMed ID: 3035878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks.
    Mavissakalian M; Perel J; Bowler K; Dealy R
    Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is buspirone effective for panic disorder?
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

  • 27. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine.
    Coleman BS; Block BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):475-8. PubMed ID: 6819596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.
    Kahn RS; Westenberg HG; Verhoeven WM; Gispen-de Wied CC; Kamerbeek WD
    Int Clin Psychopharmacol; 1987 Jan; 2(1):33-45. PubMed ID: 3312397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.
    Pollack MH; Tesar GE; Rosenbaum JF; Spier SA
    J Clin Psychopharmacol; 1986 Oct; 6(5):302-4. PubMed ID: 3771814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R; McLeod DR; Hipsley PA
    J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
    Slaap BR; van Vliet IM; Westenberg HG; den Boer JA
    J Affect Disord; 1995 Jan; 33(1):31-8. PubMed ID: 7714306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent developments in the understanding and pharmacotherapy of panic attacks.
    Liebowitz MR; Fyer AJ; Gorman J; Klein DF
    Psychopharmacol Bull; 1986; 22(3):792-6. PubMed ID: 3797584
    [No Abstract]   [Full Text] [Related]  

  • 35. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL
    J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful utilization of maprotiline in a panic disorder patient intolerant of tricyclics.
    Lydiard RB
    J Clin Psychopharmacol; 1987 Apr; 7(2):113-4. PubMed ID: 3584515
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
    Silver H; Shmugliakov N
    J Clin Psychopharmacol; 1998 Jun; 18(3):208-11. PubMed ID: 9617979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Usigli R; Zulueta A; Crocker B; Adatia N; Buckwalter JG; Baltazar P; Kurvink W; Inglove H; Kelly R
    J Clin Psychopharmacol; 1988 Jun; 8(3):204-7. PubMed ID: 3379145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
    Eberhard G; von Knorring L; Nilsson HL; Sundequist U; Björling G; Linder H; Svärd KO; Tysk L
    Neuropsychobiology; 1988; 19(1):25-34. PubMed ID: 3054623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.